BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Apr 27, 2026; 18(4): 116412
Published online Apr 27, 2026. doi: 10.4240/wjgs.v18.i4.116412
Table 7 Comparison of follow-up results between two groups, n (%)/median (interquartile rage)
Indicator
Combined navigation group (n = 103)
Conventional surgery group (n = 97)
Statistic
P value
Median follow-up time (months)29.5 (18-42)27.8 (16-40)Z = 0.8230.411
1-year overall survival rate (%)89.381.4
2-year overall survival rate (%)76.865.2
Overall survival curve comparison1Log-rank χ2 = 4.5210.033
1-year disease-free survival rate (%)72.861.9
2-year disease-free survival rate (%)58.445.7
Disease-free survival curve comparison1Log-rank χ2 = 5.2340.022
Postoperative recurrence38 (36.9)49 (50.5)χ2 = 3.9210.048
Recurrence time (months)16.8 (10.2-24.5)13.5 (8.6-20.3)Z = 2.0120.044
Recurrence site classification
    Intrahepatic recurrence only26 (25.2)34 (35.1)χ2 = 2.5120.113
    Single18 (17.5)19 (19.6)
    Multiple8 (7.8)15 (15.5)
Extrahepatic metastasis only6 (5.8)6 (6.2)χ2 = 0.0120.913
Lung metastasis4 (3.9)4 (4.1)
Bone metastasis1 (1.0)1 (1.0)
Peritoneal metastasis1 (1.0)1 (1.0)
Intrahepatic + extrahepatic metastasis6 (5.8)9 (9.3)χ2 = 0.9210.337
Total intrahepatic recurrence232 (31.1)43 (44.3)χ2 = 3.8470.05
Total extrahepatic metastasis212 (11.7)15 (15.5)χ2 = 0.6210.431


Write to the Help Desk